⚠ VINC is no longer actively traded.
Data shown reflects verified historical relationships.
1Suppliers
0Customers
1Debt Items
9Related Chains
Vincerx Pharma, Inc. Suppliers
| Ticker | Name | Confidence | Evidence |
| BAYER |
BAYER |
90%
|
given the approval by our board of directors of the Dissolution, it is expected that Bayer will terminate the License Agreement pursuant to its terms |
Vincerx Pharma, Inc. Customers
No clients on recordNo downstream customers found in our database for Vincerx Pharma, Inc..
Vincerx Pharma, Inc. Debt Obligations
| Instrument | Description | Confidence | Evidence |
| VINC-DEBT-13355 |
Warrants outstanding: 0.01 |
90%
|
xbrl warrant detail from xbrl 2024-12-31. |
Vincerx Pharma, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Vincerx Pharma, Inc..
Vincerx Pharma, Inc. Ownership
No ownership data on recordNo major institutional ownership relationships found in our database for Vincerx Pharma, Inc..
Vincerx Pharma, Inc. Extended Supply Chain Network
| Ticker | Name | Chain Index | Hops | Relationship Types |
| BPTH |
Bio-Path Holdings, Inc. |
100.00 |
2 |
|
| LLY |
Eli Lilly and Company |
100.00 |
2 |
|
| STTK |
Shattuck Labs, Inc. |
100.00 |
2 |
|
| GILD |
Gilead Sciences, Inc. |
100.00 |
2 |
|
| NRIX |
Nurix Therapeutics, Inc. |
100.00 |
2 |
|
| RIGL |
Rigel Pharmaceuticals, Inc. |
100.00 |
2 |
|
| JNJ |
Johnson & Johnson |
100.00 |
2 |
|
| CRIS |
Curis, Inc. |
36.29 |
1 |
['spend'] |
| ROCHE |
ROCHE |
23.09 |
2 |
|